Menu
Back to User profile » Professor Yali Zhang
Papers published by Professor Yali Zhang:
Inhibition of JNK Phosphorylation by Curcumin Analog C66 Protects LPS-Induced Acute Lung Injury [Corrigendum]
Xiao Z, Xu F, Zhu X, Bai B, Guo L, Liang G, Shan X, Zhang Y, Zhao Y, Zhang B
Drug Design, Development and Therapy 2022, 16:249-250
Published Date: 19 January 2022
Inhibition Of JNK Phosphorylation By Curcumin Analog C66 Protects LPS-Induced Acute Lung Injury
Xiao Z, Xu F, Zhu X, Bai B, Guo L, Liang G, Shan X, Zhang Y, Zhao Y, Zhang B
Drug Design, Development and Therapy 2019, 13:4161-4171
Published Date: 10 December 2019
A novel imidazopyridine derivative, X22, attenuates sepsis-induced lung and liver injury by inhibiting the inflammatory response in vitro and in vivo
Ge X, Feng Z, Xu T, Wu B, Chen H, Xu F, Fu L, Shan X, Dai Y, Zhang Y, Liang G
Drug Design, Development and Therapy 2016, 10:1947-1959
Published Date: 24 June 2016
Synthesis and biological evaluation of a novel class of curcumin analogs as anti-inflammatory agents for prevention and treatment of sepsis in mouse model
Zhao C, Zhang Y, Zou P, Wang J, He W, Shi D, Li H, Liang G, Yang S
Drug Design, Development and Therapy 2015, 9:1663-1678
Published Date: 18 March 2015
Discovery and evaluation of novel anti-inflammatory derivatives of natural bioactive curcumin
Zhang Y, Jiang X, Peng K, Chen C, Fu L, Wang Z, Feng J, Liu Z, Zhang H, Liang G, Pan Z
Drug Design, Development and Therapy 2014, 8:2161-2171
Published Date: 4 November 2014
Discovery and evaluation of asymmetrical monocarbonyl analogs of curcumin as anti-inflammatory agents
Zhang Y, Zhao C, He W, Wang Z, Fang Q, Xiao B, Liu Z, Liang G, Yang S
Drug Design, Development and Therapy 2014, 8:373-382
Published Date: 4 April 2014